Cboe Global Markets, Inc. (CBOE)
Live price chart, market sentiment, and community perspectives for Cboe Global Markets, Inc. (CBOE: CBOE).
Live price chart, market sentiment, and community perspectives for Cboe Global Markets, Inc. (CBOE: CBOE).
On our desk, the recent 28.4% drop over the past month looks less like a fundamental breakdown and more like a sharp de-rating from its 52-week high in May. Even though peers like ICE, CME, and Nasdaq have also pulled back, CBOE's forward P/E sitting around 22x-23x implies that a lot of high-growth expectations were already priced in. We are watching closely to see if the recent operational pivot under CEO Craig Donohue—exiting non-core cash crypto and international exchanges—will permanently establish higher low-to-mid 60s operating margins before committing fresh capital.
When evaluating candidates or junior analysts on CBOE's current positioning, focus heavily on the capital allocation narrative. Emphasize how management updated their 2026 organic total net revenue growth target to 'mid to high teens' while reaffirming adjusted operating expense guidance between $838 and $853 million. An ideal technical breakdown must reconcile their impressive data vantage growth (up 15% with robust international demand) against the headwinds of rising CapEx and competitive market-share erosion.
From a risk management standpoint, the core vulnerability is the direct linkage between record results and elevated market volatility. Q2 2026 numbers were fantastic—net revenues hit $731.6M with diluted EPS up 50%—but these metrics are hyper-sensitive to derivatives volumes, SPX Zero DTE trading, and retail engagement boosted by the repeal of the pattern day trader rule. If market volatility normalizes downward, the high operating leverage that expanded operating margins up to 65.1% (or even 72.2% on certain metrics) could quickly work in reverse.
Sentiment across institutional forums has turned cautious, prompting downgrades like Erste Group moving the stock to 'hold' from 'buy' when it traded near its peak, alongside UBS reiterating a neutral rating with a $335 price target as the stock hovered near its 52-week low of roughly $245. The market is weighing the success of new initiatives like Cboe Predicts and KPI event contracts against near-term regulatory risks and the execution risk of selling off Australian and Canadian exchange businesses.
The strategic housecleaning led by Craig Donohue is a major talking point among long-term fundamental investors. By exiting cash cryptocurrency trading in 2024, closing the Japanese exchange in 2025, and moving to divest Canadian and Australian operations in 2026, Cboe is actively reversing the unfocused spending that bloated operating expenses between 2020 and 2024. If this leaner corporate profile successfully sustains operating margins in the low-to-mid 60s, the current valuation dip might offer a compelling entry point for patient capital.
Explore plasma cleansing, somatic organ swaps, and BCI.